Human CBX2 activation kit by CRISPRa

CAT#: GA113678

CBX2 CRISPRa kit - CRISPR gene activation of human chromobox 2



  See Other Versions

CNY 12,255.00


货期*
4周

规格
    • 1 kit

Product images

经常一起买 (3)
Rabbit Polyclonal Anti-CBX2
    • 50 ug

CNY 4,628.00


CBX2 (Myc-DDK-tagged)-Human chromobox homolog 2 (CBX2), transcript variant 2
    • 10 ug

CNY 2,400.00
CNY 3,705.00


Recombinant Anti-CBX2 (Clone RAB-C238)
    • 200 ug

CNY 6,881.00

Specifications

Product Data
Format 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug)
Symbol CBX2
Locus ID 84733
Kit Components

GA113678G1, CBX2 gRNA vector 1 in pCas-Guide-GFP-CRISPRa

GA113678G2, CBX2 gRNA vector 2 in pCas-Guide-GFP-CRISPRa

GA113678G3, CBX2 gRNA vector 3 in pCas-Guide-GFP-CRISPRa

1 CRISPRa-Enhancer vector, SKU GE100056

1 CRISPRa scramble vector, SKU GE100077

Disclaimer These products are manufactured and supplied by OriGene under license from ERS. The kit is designed based on the best knowledge of CRISPRa SAM technology. The efficiency of the activation can be affected by many factors, including nucleosome occupancy status, chromatin structure and the gene expression level of the target, etc.
Reference Data
RefSeq NM_005189, NM_032647
Synonyms CDCA6; M33; SRXY5
Summary This gene encodes a component of the polycomb multiprotein complex, which is required to maintain the transcriptionally repressive state of many genes throughout development via chromatin remodeling and modification of histones. Disruption of this gene in mice results in male-to-female gonadal sex reversal. Mutations in this gene are also associated with gonadal dysgenesis in humans. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene.[provided by RefSeq, Mar 2010]
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Documents

Other Versions

Customer Reviews 
Loading...